Inspire Medical Systems, Inc.
INSP
Positions held
Your positionsINSP isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Inspire Medical Systems operates in the growing medical devices industry, focusing on innovative solutions for obstructive sleep apnea, which has a significant unmet need in the healthcare market.
- In 2025, Inspire reported a revenue of $911.981 million, reflecting a growth trajectory despite recent challenges.
- The company maintains a strong gross margin of 85.39% for the year 2025, indicating efficient cost management and product pricing.
- The company faces intense competition in the medical devices sector, which could impact its market share and pricing power.
- In the most recent quarter, Inspire experienced a revenue decline of 2% compared to the prior quarter, dropping from $205 million to $201 million.
- Inspire's operating margin was negative at -0.256 in Q2 2026, highlighting ongoing profitability challenges.
Fundamentals
| Market cap | $1.93B | Enterprise value | $1.64B | Trailing P/E | 14.69 | Forward P/E | 43.16 |
| PEG | — | Price / book | 2.34 | Beta | 0.73 | Dividend yield | 0.00% |
| Revenue growth | -7.6% | Earnings growth | — | Gross margin | 86.1% | Operating margin | -0.3% |
| Profit margin | 15.0% | ROE | 18.0% | ROA | 3.9% | Debt / equity | 0.04 |
| Current ratio | 8.55 | Free cash flow | $94.64M | Analyst recommendation | hold | Mean target | $65.00 |
| 52w high | $147.03 | 52w low | $38.91 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $201M | $205M | $269M | $225M | $217M |
| Op margin | -0.3% | -0.5% | 17.1% | 4.3% | -1.5% |
| Net income | $0.3M | -$11.3M | $136M | $9.9M | -$3.6M |
| Gross margin | 85.5% | 86.5% | 86.6% | 85.8% | 84.0% |
| Gross profit | $171M | $177M | $233M | $193M | $182M |
| Operating income | -$0.5M | -$1.1M | $46.1M | $9.6M | -$3.3M |
- Revenue -2% vs prior quarter ($201M vs $205M).
- Gross margin 85.5% (was 86.5% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $912M | $803M | $625M | $408M |
| Op margin | 5.6% | 4.5% | -6.4% | -11.7% |
| Net income | $145M | $53.5M | -$21.2M | -$44.9M |
| Gross margin | 85.4% | 84.7% | 84.5% | 83.8% |
| Gross profit | $779M | $680M | $528M | $342M |
| Operating income | $51.0M | $36.1M | -$40.3M | -$47.6M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · 3 Cash-Heavy Stocks We Steer Clear Of
2026-10-07 · Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
2026-10-07 · Barclays Initiates Inspire Medical Systems at Underweight With $65 Price Target
2026-10-06 · 1 Profitable Stock Worth Your Attention and 2 We Ignore
2026-10-05 · Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
2026-10-05 · How Investors Are Reacting To Inspire Medical Systems (INSP) Securing Category I CPT Codes For Inspire V
2026-10-05 · Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines
2026-10-05 · Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
2026-10-04 · Inspire Medical (INSP): How Much Optimism Is Baked Into This Medtech Stock?
2026-10-01 · Inspire Medical Systems Gets New CPT Codes for Hypoglossal Nerve Stimulation
2026-10-01 · RBC Raises Price Target on Inspire Medical Systems to $75 From $60, Keeps Sector Perform Rating
Price (daily)
Full chart · RSI · MACD · patterns